Publication details
Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
| Authors | |
|---|---|
| Year of publication | 2016 |
| Type | Article in Periodical |
| Magazine / Source | Annals of Oncology |
| MU Faculty or unit | |
| Citation | |
| Doi | http://dx.doi.org/10.1093/annonc/mdw329 |
| Field | Oncology and hematology |
| Keywords | RANDOMIZED CONTROLLED-TRIAL; PHASE-III TRIAL; NEOADJUVANT CHEMORADIOTHERAPY; BARRETTS-ESOPHAGUS; JUNCTIONAL CANCER; ESPEN GUIDELINES; OPEN-LABEL; SURGERY; METAANALYSIS; MULTICENTER |
| Description | Oesophageal cancer is the 19th most common cancer in the European Union (EU), with cca 45 900 new cases diagnosed in 2012 (1% of the total). In the EU, the highest age-standardised incidence rates for oesophageal cancer are in the Netherlands for men and the UK for women [1]. Variation between countries is high and may reflect different prevalence of risk factors, use of screening and diagnostic methods. |